BA
IART icon

Bridgewater Associates’s Integra LifeSciences IART Stock Holding History

Bridgewater Associates’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,533
Closed -$537K – 757
2024
Q3 		$537K Sell
29,533
-83,807
-74% -$1.94M ﹤0.01% 683
2024
Q2 		$3.3M Buy
113,340
+46,720
+70% +$1.39M 0.02% 438
2024
Q1 		$2.36M Sell
66,620
-9,754
-13% -$390K 0.01% 474
2023
Q4 		$3.33M Sell
76,374
-11,791
-13% -$464K 0.02% 432
2023
Q3 		$3.37M Buy
88,165
+6,257
+8% +$263K 0.02% 418
2023
Q2 		$3.37M Sell
81,908
-8,180
-9% -$394K 0.02% 381
2023
Q1 		$5.17M Buy
90,088
+4,051
+5% +$228K 0.03% 304
2022
Q4 		$4.82M Sell
86,037
-29,470
-26% -$1.5M 0.03% 368
2022
Q3 		$4.89M Buy
115,507
+424
+0.4% +$21.7K 0.02% 383
2022
Q2 		$6.22M Buy
115,083
+10,810
+10% +$649K 0.03% 440
2022
Q1 		$6.7M Buy
104,273
+23,292
+29% +$1.53M 0.03% 387
2021
Q4 		$5.42M Buy
80,981
+6,018
+8% +$407K 0.03% 276
2021
Q3 		$5.13M Buy
74,963
+5,081
+7% +$359K 0.03% 285
2021
Q2 		$4.77M Buy
+69,882
New +$4.94M 0.03% 337

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridgewater Associates's IART Position: Q4 2024 in Review

Bridgewater Associates sold out of Integra LifeSciences (IART) in Q4 2024, closing a stake of 29,533 shares — an estimated $537K sold.

Bridgewater Associates first reported a position in IART in Q2 2021 and held it in 14 quarters. The position peaked at $6.7M in Q1 2022. 223 funds tracked by Wall St. Rank hold IART as of Q4 2024.

  • Bridgewater Associates reported no remaining Integra LifeSciences position as of Q4 2024 after selling out during the quarter.
  • Bridgewater Associates sold 29,533 Integra LifeSciences shares in Q4 2024, an estimated $537K.
  • Bridgewater Associates first reported a position in Integra LifeSciences in Q2 2021 and held it in 14 quarters.
  • Bridgewater Associates's Integra LifeSciences position peaked at $6.7M in Q1 2022.
  • 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2024.

Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.